Back to search

United States· US:42806-269_00990dec-7618-4cc8-9387-48c2cea8df1c

CHOLESTYRAMINE LIGHT

A colestyramine product containing cholestyramine light, registered in United States by EPIC PHARMA, LLC. The same ATC class is registered in 13 of our 19 countries.

ATC C10AC01Orange BookUS label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedCHOLESTYRAMINE LIGHTATCC10AC01REGISTER NO.US:42806-269_00990dec…PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Colestyramine is registered in 13 of 19 countries.

Countries holding a registration under ATC C10AC01 (colestyramine), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 7 of them publish a price we can compare per daily dose

Colestyramine · ATC C10AC01

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
cholestyramine light
Manufacturer
EPIC PHARMA, LLC
Country
United States (US)
ATC code
C10AC01
ATC class
Colestyramine
Defined daily dose
14 g, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 12, 2026

Packs & prices · 1

  • ndc11
    4280626998
    5.7 g in 1 POUCH (42806-269-98)

Regulatory notes

UNII (FDA substance ID)
4B33BGI082
CHOLESTYRAMINE
RxCUI 2447
Orange Book
A074558
ABAB
DailyMed SPL labels
1 version tracked

Interactions

88 interactions on record for colestyramine.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Colestyramine · interactions on record

88 records

  • 3 severe
  • 73 moderate
  • 7 minor

Most severe, free to view

  • Mycophenolic acidL04AA06severe
  • TeriflunomidL04AA31severe
  • TeriflunomideL04AK02severe
  • Chenodeoxycholic acidA05AA01moderate

5 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Colestyramine in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All colestyramine products

Authorised across Europe · EMA

The same active substance is authorised in 17 EEA countries. Names it is sold under:

  • Austria · Quantalan Zuckerfrei
  • Belgium · Questran
  • Cyprus · Resincolestiramina
  • Germany · Colestyramin 1 A Pharma, Colestyramin Ratiopharm
  • Denmark · Colestyramin Orifarm
  • Spain · Efensol, Resincolestiramina
  • Finland · Questran
  • France · Questran
  • United Kingdom (Northern Ireland) · Colestyramine Light Laboratorios Rubió, Colestyramine Neon Healthcare
  • Hungary · Cholestyramine
  • Ireland · Questran
  • Italy · Questran
  • Luxembourg · Questran
  • Netherlands · Colestyramine Suikervrij Focus, Questran
  • Norway · Questran, Questran Loc
  • Portugal · Quantalan
  • Sweden · Kolestyramin Alternova, Questran

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cbf01083-30bf-496b-b032-a8d97e523556
GET /v1/drugs/cbf01083-30bf-496b-b032-a8d97e523556?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unii": {
    "unii": "4B33BGI082",
    "rxcui": "2447",
    "inchikey": null,
    "display_name": "CHOLESTYRAMINE",
    "substance_type": "polymer",
    "ingredient_type": "INGREDIENT SUBSTANCE"
  },
  "route": "ORAL",
  "livertox": {
    "summary": null,
    "livertox_id": null,
    "hepatotoxicity_score": 5
  },
  "spl_meta": {
    "acc48703-c15b-4275-aa75-749f1c07dcbb": {
      "match": "brand_token",
      "title": "CHOLESTYRAMINE POWDER, FOR SUSPENSION [ZYDUS PHARMACEUTICALS (USA) INC.]",
      "spl_version": "6",
      "published_date": "2026-04-29"
    }
  },
  "productid": "42806-269_00990dec-7618-4cc8-9387-48c2cea8df1c",
  "productndc": "42806-269",
  "dosage_form": "POWDER, FOR SUSPENSION",
  "orange_book": {
    "appl_no": "074558",
    "products": [
      {
        "rs": true,
        "rld": false,
        "te_code": "AB",
        "strength": "EQ 4GM RESIN/PACKET",
        "product_no": "001",
        "approval_date": "Aug 15, 1996"
      },
      {
        "rs": false,
        "rld": false,
        "te_code": "AB",
        "strength": "EQ 4GM RESIN/SCOOPFUL",
        "product_no": "002",
        "approval_date": "Aug 15, 1996"
      }
    ],
    "appl_type": "A"
  },
  "dea_schedule": null,
  "product_type": "HUMAN PRESCRIPTION DRUG",
  "substance_name": "CHOLESTYRAMINE",
  "proprietary_name": "CHOLESTYRAMINE LIGHT",
  "active_ingred_unit": "g/5.7g",
  "application_number": "ANDA074558",
  "marketing_category": "ANDA",
  "nonproprietary_name": "cholestyramine light",
  "start_marketing_date": "20211215",
  "active_numerator_strength": "4"
}

See everything about colestyramine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.